Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

120.56
-2.4000-1.95%
Post-market: 120.560.00000.00%17:07 EDT
Volume:964.82K
Turnover:116.58M
Market Cap:11.93B
PE:40.77
High:122.42
Open:122.42
Low:119.79
Close:122.96
Loading ...
Feb 11, 2022

Major Issues Report

8-K - Current report
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2022

Major Issues Report

8-K - Current report
Dec 23, 2021

Major Issues Report

8-K - Current report
Dec 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 01, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Dec 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 12, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 12, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2021

Major Issues Report

8-K - Current report
Apr 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals